Law

The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024

United Kingdom · regulation

Ask the law about thisMore laws of United KingdomFor machines: Markdown

Open at the publisher →

In force since 2025-01-31, as the publisher states.

Copy read on 2026-11-10. The page it was read from

Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

sha256 0b190377af1f3691cb1d03f193da1eeeba2c3f4b37a08a8572fc1525897bb097

Contents: 6 provisions
  1. Title and introductory text
  2. 1 Citation, commencement and extent
  3. 2 Amendment to Regulation (EC) No 1223/2009
  4. 3 Transitional Provisions
  5. Schedule 1 Amendments to Annex 2
  6. Schedule 2 Amendment to Annex 3

Proposed changes to this act

No one has proposed a change to this act yet.

6 provisions

Title and introductory text

2024 No. 1334 CONSUMER PROTECTION The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024 Made 11th December 2024 Laid before Parliament 17th December 2024 Coming into force 31st January 2025 The Secretary of State makes these Regulations in exercise of the powers conferred by Articles 31(1)(b), 31(1)(f) and 32(1)(b) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (“the Regulation”). In accordance with Article 31(1)(b) of the Regulation, the Secretary of State considers there is sufficient scientific evidence that there is a potential risk to human health arising from the use, in cosmetic products, of the substance set out in Schedule 2 to these Regulations. In accordance with Article 31(1)(f) of the Regulation, the substances set out in Schedule 1 to these Regulations have been classified as CMR substances of category 1A, 1B or 2 under Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures.

Propose a change

1 Citation, commencement and extent

(1) These Regulations may be cited as the Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024 and come into force on 31st January 2025. (2) These Regulations extend to England and Wales and Scotland.

Propose a change

2 Amendment to Regulation (EC) No 1223/2009

(1) Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products is amended as follows. (2) At the end of the table in Annex 2 (list of substances prohibited in cosmetic products), insert the entries set out in Schedule 1 to these Regulations. (3) At the end of the table in Annex 3 (list of substances which cosmetic products must not contain except subject to the restrictions laid down), insert the entries set out in Schedule 2 to these Regulations.

Propose a change

3 Transitional Provisions

(1) Notwithstanding the amendments in regulation 2(2), cosmetic products containing any of the substances set out in Schedule 1 to these Regulations at reference numbers 1680 to 1730 that are placed on the market on or before 20th April 2025 may continue to be made available on the market on or before 20th October 2025. (2) Notwithstanding the amendments in regulation 2(2), cosmetic products containing any of the substances set out in Schedule 1 to these Regulations at reference numbers 1731 to 1743 that are placed on the market on or before 2nd September 2025 may continue to be made available on the market on or before 2nd March 2026. (3) Notwithstanding the amendment in regulation 2(3), cosmetic products that are placed on the market on or before 20th June 2025 may continue to be made available on the market on or before 1st November 2025.

Propose a change

Schedule 1 Amendments to Annex 2

Regulation 2(2) 1680 | Tetrafluoroethylene | 116-14-3 | 204-126-9 1681 | 6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; [DBMC] | 119-47-1 | 204-327-1 1682 | (5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone | 688046-61-9 | 692-456-8 1683 | (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate | 1101132-67-5 1684 | 3-methylpyrazole | 1453-58-3 | 215-925-7 1685 | N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide; Pydiflumetofen | 1228284-64-7 1686 | N-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}- 3-(difluoromethyl)-1-methyl-1Hpyrazole-4-carboxamide; Sedaxane | 874967-67-6 1687 | Thiophanate-methyl (ISO); dimethyl (1,2- phenylenedicarbamothioyl)biscarbamat; dimethyl 4,4’-(o-phenylene)bis(3- thioallophanate) | 23564-05-8 | 245-740-7 1688 | Mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt | 8018-01-7 1689 | Trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] | 12035-72-2 [1] 12035-71-1 [2] | 234-829-6 [1] – [2] 1690 | 7-oxa-3-oxiranylbicyclo[4.1.0]heptane; 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide | 106-87-6 | 203-437-7 1691 | 4-methylpentan-2-one; isobutyl methyl ketone (MIBK) | 108-10-1 | 203-550-1 1692 | Carbendazim (ISO); methyl benzimidazole-2-ylcarbamat | 10605-21-7 | 234-232-0 1693 | Dimethomorph (ISO); (E,Z)-4-(3-(4- chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine | 110488-70-5; (1135441-72-3) | 404-200-2 1694 | 1,2,4-triazole | 288-88-0 | 206-022-9 1695 | Flumioxazin (ISO); N-(7-fluoro-3,4- dihydro-3-oxo-4-prop-2-ynyl-2H-1,4- benzoxazin-6-yl)cyclohex-1-ene-1,2- dicarboximide | 103361-09-7 1696 | Imazamox (ISO); (RS)-2-(4-isopropyl-4- methyl- 5-oxo-2-imidazolin-2-yl)-5- methoxymethylnicotinic acid | 114311-32-9 1697 | Thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5- methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine | 153719-23-4 | 428-650-4 1698 | Triticonazole (ISO); (RS)-(E)-5-(4- chlorobenzylidene)-2,2-dimethyl-1-(1H1,2,4-triazol-1-ylmethyl)cyclopentanol | 138182-18-0 1699 | Desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate | 13684-56-5 | 237-198-5 1700 | Tellurium dioxide | 7446-07-3 | 231-193-1 1701 | Tellurium | 13494-80-9 | 236-813-4 1702 | Fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5- (trifluoromethyl)-2- pyridylmethyl]benzamide | 239110-15-7 | 607-285-6 1703 | Daminozide (ISO); 4-(2,2- dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid | 1596-84-5 | 216-485-9 1704 | Benzophenone | 119-61-9 | 204-337-6 1705 | Acetamiprid (ISO); (1E)-N-[(6- chloropyridin-3- yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N 1 -[(6- chloro-3-pyridyl)methyl]-N 2 -cyano-N 1 – methylacetamidine | 135410-20-7 | 603-921-1 1706 | Theophylline; 1,3-dimethyl-3,7-dihydro-1 H-purine-2,6-dione | 58-55-9 | 200-385-7 1707 | N-(2-nitrophenyl)phosphoric triamide | 874819-71-3 | 477-690-9 1708 | Dibutyltin di(acetate) | 1067-33-0 | 213-928-8 1709 | Dibutyltin bis(2-ethylhexanoate) | 2781-10-4 | 220-481-2 1710 | Cumene | 98-82-8 | 202-704-5 1711 | Barium diboron tetraoxide | 13701-59-2 | 237-222-4 1712 | 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3- propanediyldiacrylate; 2,2- bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate | 15625-89-5 | 239-701-3 1713 | Quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone | 2797-51-5 | 220-529-2 1714 | Pendimethalin (ISO); N-(1-ethylpropyl)- 2,6-dinitro-3,4-xylidene | 40487-42-1 | 254-938-2 1715 | Isoflucypram (ISO); N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide | 1255734-28-1 1716 | Dimoxystrobin (ISO); (2E)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2- (methoxyimino)-N-methylacetamide; (E)-2- (methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide | 149961-52-4 | 604-712-8 1717 | 2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2- bis(bromomethyl)propan-1-ol | 36483-57-5; 1522-92-5 | 253-057-0 1718 | 2,4,6-tri-tert-butylphenol | 732-26-3 | 211-989-5 1719 | Ammonium bromide | 12124-97-9 | 235-183-8 1720 | Divanadium pentaoxide; Vanadium pentoxide | 1314-62-1 | 215-239-8 1721 | Bentazone (ISO); 3-isopropyl-2,1,3- benzothiadiazine-4-one-2,2-dioxide | 25057-89-0 | 246-585-8 1722 | Margosa extract. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] | 84696-25-3 | 283-644-7 1723 | Valifenalate (ISO); methyl N-(isopropoxycarbonyl)-L-valyl- (3RS)-3- (4-chlorophenyl)-β-alaninate | 283159-90-0 1724 | Isopyrazam (ISO); reaction mass of 3-(difluoromethyl)-1-methyl-N- [(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4- methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4- tetrahydro-9-isopropyl-1,4-methanonaphthalen-5- yl]pyrazole-4-carboxamide [>78% syn isomers ≤ 15% anti isomers relative content]; | 881685-58-1 1725 | Perfluoroheptanoic acid; tridecafluoroheptanoic acid | 375-85-9 | 206-798-9 1726 | 4,4’-sulphonyldiphenol; bisphenol S | 80-09-1 | 201-250-5 1727 | 6-[C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (tetra-PSCA) | 2156592-54-8 | 701-118-1 1728 | 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (Penta-PSCA) | 701-162-1 1729 | [C12-18-alkyl-(branched, unsaturated)- 2,5-dioxopyrrolidin-1-yl] hexanoic acid, sodium and tris(2-hydroxyethyl) ammonium salts; (penta-PSCA Na-TEA) | 701-271-4 1730 | 1,3,5-triazine-2,4,6-triamine; melamine | 108-78-1 | 203-615-4 1731 | Benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate | 577705-90-9 | 479-100-5 1732 | Benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1) | 75768-65-9 | 278-305-5 1733 | Reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1) 1734 | Reaction mass of 4,4'-[2,2,2-trifluoro 1-(trifluoromethyl)ethylidene] diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]bis[phenol] (1:1) 1735 | Reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2- ((2,3-epoxypropoxy)methyl) -2-hydroxymethyl butane 1736 | 4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]diphenol; bisphenol AF | 1478-61-1 | 216-036-7 1737 | Transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate | 118712-89-3 | 405-060-5 1738 | Salts of 2-ethylhexanoic acid 1739 | Benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine | 1861-40-1 | 217-465-2 1740 | N,N-dimethyl-p-toluidine | 99-97-8 | 202-805-4 1741 | 4-nitrosomorpholine | 59-89-2 1742 | 3,3'-dimethylbiphenyl 4,4'-diyl diisocyanate | 91-97-4 | 202-112-7 1743 | Foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea | 173159-57-4

Propose a change

Schedule 2 Amendment to Annex 3

Regulation 2(3) 323 | 5-hydroxy-2-(hydroxymethyl)pyran-4-one | Kojic acid | 501-30-4 | 207-922-4 | Face and hand products | 1%

Propose a change

← Find another law